Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Sale of Astra Tech to DENTSPLY International complete
-
Positive agreement received for approval of AXANUM (low-dose ASA/esomeprazole) in Europe
-
AstraZeneca PLC Second quarter and half year results 2011
-
FDA approves new medicine BRILINTA (ticagrelor) for use in the US
-
FDA Advisory Committee makes recommendation on investigational compound dapagliflozin
-
AstraZeneca's NEXIUM receives first regulatory approval in Japan for the treatment of acid-related diseases
-
Bristol Myers Squibb and AstraZeneca announce investigational compound DAPAGLIFLOZIN sustained glycemic control and weight reduction in study of Type2 Diabetes patients inadequately controlled with metformin
-
AstraZeneca to sell AstraTech to DENTSPLY International
-
AstraZeneca extends its investment in Russia with new predictive science centre in St Petersburg
-
Health Canada approves BRILINTA (ticagrelor tablets)
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here